4//SEC Filing
Liu Linda 4
Accession 0001123292-20-000301
CIK 0001661059other
Filed
Feb 20, 7:00 PM ET
Accepted
Feb 21, 4:11 PM ET
Size
10.5 KB
Accession
0001123292-20-000301
Insider Transaction Report
Form 4
NextCure, Inc.NXTC
Liu Linda
SVP, Research
Transactions
- Exercise/Conversion
Common Stock
2019-11-27$0.48/sh+34,489$16,555→ 34,489 total - Exercise/Conversion
Common Stock
2019-11-27$1.21/sh+20,745$25,101→ 55,234 total - Exercise/Conversion
Employee Stock Option (Right to Buy)
2019-11-27−34,489→ 9,076 totalExercise: $0.48Exp: 2026-09-01→ Common Stock (34,489 underlying) - Exercise/Conversion
Employee Stock Option (Right to Buy)
2019-11-27−20,745→ 10,373 totalExercise: $1.21Exp: 2027-03-15→ Common Stock (20,745 underlying)
Footnotes (2)
- [F1]One fourth of the option vested on September 1, 2017. The remainder vests in 36 monthly installments beginning on October 1, 2017.
- [F2]One fourth of the option vested on March 15, 2018. The remainder vests in 36 monthly installments beginning on April 15, 2018.
Documents
Issuer
NextCure, Inc.
CIK 0001661059
Entity typeother
Related Parties
1- filerCIK 0001775427
Filing Metadata
- Form type
- 4
- Filed
- Feb 20, 7:00 PM ET
- Accepted
- Feb 21, 4:11 PM ET
- Size
- 10.5 KB